| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 218,357 | 447,047 | 260,396 | 880,522 | | Cost of Revenue | 68,813 | 297,764 | 49,921 | 495,733 | | | Gross Profit | 149,544 | 149,283 | 210,475 | 384,789 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 59,906 | 35,581 | 29,750 | 263,534 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 49,706 | 46,188 | 44,589 | 39,731 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 39,932 | 67,514 | 136,136 | 81,524 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 511 | 698 | 590 | (11,859) | | Earnings Before Interest And Taxes | 42,393 | 69,822 | 137,848 | 102,379 | | Interest Expense | 32,393 | 26,460 | 19,243 | 17,402 | | Income Before Tax | 10,000 | 43,362 | 118,605 | 84,977 | | Income Tax Expense | 7,091 | 16,717 | 46,612 | 24,482 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,909 | 26,645 | 71,993 | 33,495 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,909 | 26,645 | 71,993 | 33,495 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,909 | $26,645 | $71,993 | $33,495 |
|
0.01% Nasdaq 
Income Statement
